Table 2 Sedentary time (ST), moderate-to-vigorous physical activity (MVPA) and metabolic parameters at three time points in pregnancy.
n | T1 (<20 weeks) | n | T2 (24–28 weeks) | n | T3 (35–37 weeks) | |
|---|---|---|---|---|---|---|
Wear time, min/day (mean ± SD) | 200 | 827.9 ± 87.6 | 196 | 802.5 ± 91.4a | 176 | 789.1 ± 96.7b |
Sedentary time, min/day (mean ± SD) | 200 | 576.9 ± 99.6 | 196 | 575.3 ± 105.0 | 176 | 576.0 ± 94.7 |
Sedentary time, % of wear time (mean ± SD) | 200 | 69.7 ± 9.5 | 196 | 71.5 ± 9.4a | 176 | 73.0 ± 8.1 |
MVPA, min/day (median (IQR)) | 200 | 38.1 (23.7–53.0) | 196 | 34.0 (21.0–50.8)a | 176 | 29.6 (15.7–41.9)b |
MVPA, % of wear time (median (IQR)) | 200 | 4.5 (2.9–6.3) | 196 | 4.0 (2.5–6.6) | 176 | 3.7 (2.0–5.0)b |
Fasting glucose, mmol/l (mean ± SD) | 232 | 4.7 ± 0.4 | 226 | 4.6 ± 0.4a | 215 | 4.6 ± 0.4 |
1 h glucose, mmol/l (mean ± SD) | 213 | 6.8 ± 1.4 | 223 | 7.5 ± 1.5a | 194 | 8.0 ± 1.4b |
2 h glucose, mmol/l (mean ± SD) | 213 | 5.8 ± 1.2 | 224 | 6.2 ± 1.3a | 194 | 6.6 ± 1.2b |
Fasting insulin, mU/l (median (IQR)) | 227 | 13.1 (9.3–17.5) | 226 | 14.7 (11.0–18.6)a | 214 | 16.7 (12.7–23.1)b |
1 h insulin, mU/l (median (IQR)) | 209 | 78.5 (53.5–151.1) | 219 | 127.1 (68.7–176.5)a | 194 | 178.9 (120.5–236.5)b |
2 h insulin, mU/l (median (IQR)) | 208 | 56.5 (38.6–86.2) | 220 | 71.2 (46.7–122.5)a | 193 | 123.8 (67.4–185.8)b |
HOMA-IR (median (IQR)) | 227 | 2.7 (1.9–3.6) | 224 | 3.0 (2.2–3.9)a | 213 | 3.4 (2.6–4.8)b |
Stumvoll first phase (median (IQR)) | 206 | 1498.9 (1234.6–2035.4) | 215 | 1820.2 (1353.7–2319.6)a | 192 | 2592.5 (2031.7–3374.9)b |
Stumvoll second phase (median (IQR)) | 206 | 385.0 (320.6–520.2) | 215 | 468.8 (352.3–590.6)a | 192 | 658.3 (522.0–846.5)b |